Skip to main content
. Author manuscript; available in PMC: 2024 Mar 25.
Published in final edited form as: Vaccine. 2019 Sep 28;37(51):7470–7477. doi: 10.1016/j.vaccine.2019.09.079

Table 2.

Invasive disease potential of pneumococcal serotypes among children aged <5 years pre- and post-PCV10 introduction in Mozambique.

Serotype Pre-PCV10
Post-PCV10
Invasive Carriage OR 95% CI P value Invasive Carriage OR 95% CI P value
1 2 1 22.3 2.0–251.2 0.041 3 0 NA NA NA
4 2 6 3.7 0.7–18.8 0.291 0 4 NA NA NA
5 2 0 NA NA NA 1 1 18.6 1.1–304.6 0.205
6B 6 23 3.1 1.2–8.1 0.017 2 25 1.5 0.3–6.5 0.845
9V 2 9 2.4 0.5–11.6 0.487 0 11 NA NA NA
14 5 17 3.4 1.2–9.8 0.016 0 14 NA NA NA
18C 1 5 2.1 0.2–18.9 0.839 0 1 NA NA NA
19F 3 59 0.5 0.1–1.7 0.375 1 37 0.5 0.1–3.5 0.779
23F 4 52 0.8 0.3–2.3 0.911 1 43 0.4 0.1–3.0 0.615
3 1 7 1.5 0.2–12.7 >0.910 0 13 NA NA NA
6A 7 43 1.9 0.8–4.5 0.152 11 47 6.1 2.7–13.5 0.001
19A 0 17 NA NA NA 2 38 0.9 0.2–4.1 >0.910
7C 1 8 1.3 0.2–10.9 >0.910 2 29 1.3 0.3–5.5 0.992
8 1 1 10.9 0.7–176.8 0.330 0 3 NA NA NA
9N 0 6 NA NA NA 1 6 3.1 0.4–26.3 0.633
12F 0 3 NA NA NA 1 0 NA NA NA
13 0 25 NA NA NA 3 33 1.7 0.5–5.9 0.585
15B 1 18 0.6 0.1–4.4 0.910 0 21 NA NA NA
18A 1 2 5.4 0.5–61 0.475 0 1 NA NA NA
35B 1 14 0.8 0.1–5.9 >0.910 0 14 NA NA NA
NT 0 23 NA NA NA 2 43 0.8 0.2–3.6 >0.910
Other 1 0 85 NA NA NA 0 156 NA NA NA
Total 40 424 30 540

95% CI: 95% confidence interval.

OR: Odds ratio.

NA: Not applicable.

1

Pre-PCV10 Include serotypes: 7B, 9A, 9L, 10A, 10B, 11A, 15A, 15C, 16F, 17F, 19B, 20, 21, 22A, 23A, 23B, 24F, 28F, 31, 33D, 34, and 35A. Post-PCV10 include serotypes: 6C, 9L, 10A, 11A, 15A, 15C, 16F, 17F, 19B, 20, 21, 23A, 23B, 24F, 28F, 29, 31, 33C, 34, 35F, 38, and 46.